Month: March 2019

LAUSANNE, Switzerland, March 1, 2019 /PRNewswire/ — First randomized clinical trial comparing the efficacy and safety of combined doxycycline 40 mg modified release (DMR) and ivermectin 1% cream (IVM), versus…

SHANGHAI, March 1, 2019 /PRNewswire/ — CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for cancer, today announced that one of its leading drug…

SAN MATEO, California, March 1, 2019 /PRNewswire/ — Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoimmunotherapy platform, today announced that it has changed its…

SHANGHAI, March 1, 2019 /PRNewswire/ — Sanofi announced that Pius S. Hornstein, PhD, has been appointed the new General Manager China, China & Emerging Markets Global Business Unit (GBU) of…